Thiazolidinediones and hepatic fibrosis: Don't wait too long

Gut

Volumn 55, Issue 7, 2006, Pages 917-919

  Marra, F ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; ROSIGLITAZONE; TROGLITAZONE;

CELL PROLIFERATION; CHRONIC LIVER DISEASE; DRUG EFFICACY; DRUG MECHANISM; FIBROGENESIS; LIVER FIBROSIS; NONHUMAN; NOTE; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT OUTCOME;

DRUG ADMINISTRATION SCHEDULE; HUMANS; HYPOGLYCEMIC AGENTS; LIVER CIRRHOSIS; THIAZOLIDINEDIONES;

EID: 33745512602     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2005.085399     Document Type: Note

References (24)

1. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005;115:209-18.
2. Cassiman D, Libbrecht L, Desmet V, et al. Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers. S Hepatol 2002;36:200-9.
3. Yki-Jarvinen H. Thiazolidinediones. N Engl J Med 2004;351:1106-18.
4. Shulman AI, Mangelsdorf DJ. Retinoid x receptor heterodimers in the metabolic syndrome. N Engl J Med 2005;353:604-15.
5. Bailey ST, Ghosh S. 'PPAR'ting ways with inflammation. Nat Immunol 2005;6:966-7.
6. Galli A, Crabb D, Price D, et al. Peroxisome proliferator-activated receptor gamma transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cells. Hepatology 2000;31:101-8.
7. Marra F, Efsen E, Romanelli RG, et al. Ligands of peroxisome proliferator-activated receptor gamma modulate profibrogenic and proinflammatory actions in hepatic stellate cells. Gastroenterology 2000;119:466-78.
8. Miyahara T, Schrum L, Rippe R, et al. Peroxisome proliferator-activated receptors and hepatic stellate cell activation. J Biol Cnem 2000;275:35715-22.
9. Planaguma A, Claria J, Miquel R, et al. The selective cyclooxygenase-2 inhibitor SC-236 reduces liver fibrosis by mechanisms involving non-parenchymal cell apoptosis and PPARgamma activation. FASEB J 2005;19:1120-2.
10. Galli A, Crabb DW, Ceni E, et al. Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro. Gastroenterology 2002;122:1924-40.
11. Hazra S, Xiong S, Wang J, et al. Peroxisome proliferator-activated receptor gamma induces a phenotypic switch from activated to quiescent hepatic stellate cells. J Biol Chem 2004;279:11392-401.
12. She H, Xiong S, Hazra S, et al. Adipogenic transcriptional regulation of hepatic stellate cells. J Biol Chem 2005;280:4959-67.
13. Kawaguchi K, Sakaida I, Tsuchiya M, et al. Pioglitazone prevents hepatic steatosis, fibrosis, ana enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet, Biochem Biophys Res Commun 2004;315:187-95.
14. Kon K, Ikejima K, Hirose M, et al Pioglitazone prevents early-phase hepatic fibrogenesis caused by carbon tetrochloride. Biochem Biophys Res Commun 2002;291:55-61.
15. Marra F, DeFranco R, Robino G, et al. Thiazolidinedione treatment inhibits bile duct proliferation and fibrosis in a rat model of chronic cholestasis. World J Gastroenterol 2005;11:4931-8.
16. Leclercq IA, Sempoux C, Starkel P, et al. Limited therapeutic efficacy of pioglitazone on progression of hepatic fibrosis in rats. Gut 2006;55:1020-9.
17. Greupink R, Bakker HI, Reker-Smit C, et al. Studies on the targeted delivery of the antifibrogenic compound mycophenolic acid to the hepatic stellate cell. J Hepotol 2005;43:884-92.
18. Li L, Tao J, Davaille J, et al. 15-Deoxy-delta 12,14-prostaglandin 12 induces apoptosis of human hepatic myofibroblasts. A pathway involving oxidative stress independently of peroxisome-proliferator-activated receptors. J Biol Chem 2001;276:38152-8.
19. Inagaki Y, Kushida M, Higashi K, et al. Cell type-specific intervention of transforming growth factor beta/Smad signaling suppresses collagen gene expression and hepatic Fibrosis in mice. Gastroenterology 2005;129:259-68.
20. Tsui TY, Lau CK, Ma J, et al. rAAV-mediated stable expression of heme oxygenase-1 in stellate cells: a new approach to attenuate liver fibrosis in rats. Hepatology 2005;42:335-42.
21. Dooley S, Hamzavi J, Breitkopf K, et al. Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats. Gostroenterology 2003;125:178-91.
22. Neuschwander-Tetri BA, Brunt EM, Wehmeier KR, et al. Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone. Hepatology 2003;38:1008-17.
23. Promrat K, Lutchman G, Uwaifo GI, et al. A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis. Hepatology 2004;39:188-96.
24. Powell EE, Jonsson JR, Clouston AD. Steatosis: co-factor in other liver diseases. Hepatology 2005;42:5-13.